A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH.

Clinical trial NCT00855465 · COMPLETED

Trial details

NCT number: NCT00855465
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Pulmonary Hypertension

Start date: 2009-02-23
Primary completion: 2012-06-27
Enrollment: 262

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.